Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Prednisolone for Acute Rhinovirus Induced Wheezing
NCT05444699Phase 4Recruiting
- Sponsor
- University of Oulu
- Start
- Oct 2022
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Acute viral bronchiolitis (AVB) comparing Prednisolone with Placebo (2 arms). Primary endpoint: Length of hospital stay at 7 days. Started Oct 2022; status: recruiting.
02
Drugs
prednisolone
03
Conditions
Acute viral bronchiolitis (AVB)
Beyond the preview
Go deeper on NCT05444699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05444699.